Sitcs guide managing immunotherapy (3 Ergebnisse)
- Weitere Bilder
- Softcover
Anbieter: Bookbot, Prague, TschechienBookbot
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Gebraucht - Wie neu
EUR 7,01
EUR 20,99 VersandVersand von Tschechien nach USAAnzahl: 1 verfügbar
Softcover. Zustand: As New. Leichte Kratzer / Abnutzungen / Druckstellen. The Society for Immunotherapy of Cancer's handbook, SITC's Guide to Managing Immunotherapy Toxicity, serves as a practical reference for managing side effects linked to FDA-approved cancer immunotherapy drugs. It is divided into two parts: Part I offers ch…apter-based overviews of immune checkpoint inhibitors, including anti-CTLA4 and anti-PD1/PD-L1 agents, along with approved combinations. These chapters detail mechanisms of action, indications, and toxicities encountered in early, advanced, and metastatic cancer patients. Part II focuses on common and uncommon toxicities affecting major organ sites. It begins with a general summary of management principles, followed by specific chapters on toxicities such as rash, mucosal irritation, joint and muscle toxicity, diarrhea, pneumonitis, endocrine, neurological, cardiac, renal, hematologic, and ocular toxicities. Each chapter provides guidance on assessing and treating these toxicities, with detailed summary tables for quick reference. Additionally, Part II addresses the management of special patient populations, including those with autoimmune diseases and geriatric patients, as well as treatment for fatigue and the financial impact of care. Written by leading experts in immuno-oncology, this text is an essential resource for clinical oncologists, emergency physicians, and other medical practitioners in both hospital and community settings, especially as immune checkpoint inh.
- Softcover
Anbieter: Revaluation Books, Exeter, Vereinigtes KönigreichRevaluation Books
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 92,86
EUR 11,67 VersandVersand von Vereinigtes Königreich nach USAAnzahl: 2 verfügbar
Paperback. Zustand: Brand New. 1st pap/psc edition. 246 pages. 8.00x5.00x0.65 inches. In Stock.
- Weitere Bilder
- Softcover
Anbieter: AHA-BUCH GmbH, Einbeck, DeutschlandAHA-BUCH GmbH
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 96,00
EUR 61,59 VersandVersand von Deutschland nach USAAnzahl: 2 verfügbar
Taschenbuch. Zustand: Neu. Neuware - The Society for Immunotherapy of Cancer's handbook,SITC's Guide to Managing Immunotherapy Toxicity, is a practical reference to managing side effects associated with FDA-approved cancer immunotherapy drugs. Separated into two parts, Part I contains chapter-based overviews of immune checkpoint… inhibitors in the clinic, starting with anti-CTLA4 agents, anti-PD1/PD-L1 agents, and approved immunotherapeutic combinations. These chapters cover relevant mechanisms of action, indications, and toxicities seen while combating early, advanced, and metastatic stages in cancer patients. Part II is structured by common and uncommon toxicities that affect major organ sites throughout the body. It begins with a general summary of principles and management options followed by chapters focusing on specific toxicities such as rash and mucosal irritation, muscle and joint toxicity, diarrhea and colitis, pneumonitis, endocrine toxicities, neurological toxicities, cardiac toxicity, renal toxicity, hematologic toxicity, and ocular toxicities. Each chapter provides guidance on how to assess and treat the toxicity and how to support the patient through acute and chronic effects with detailed summary tables for quick reference. Part II concludes with chapters covering management of special patient populations, including patients with autoimmune disease and geriatric patients, treatment and management of fatigue, and a final chapter dedicated to cost effectiveness and the toll of financial toxicity on patients and caregivers.With chapters written by world-recognized leaders in the immuno-oncology field, this text provides thorough coverage of the toxicity and management of adverse effects for immune checkpoint inhibitors. It is an indispensable resource for clinical oncologists, emergency physicians, hospitalists and other medical practitioners in both the hospital and community clinic settings, especially as the use of immune checkpoint inhibitors becomes a fixture in oncology care.Key Features:- Outlines strategies for treating high-risk patients facing an acute or chronic side effect to immunotherapy- Provides numerous tables that condense and highlight pertinent information for quick reference- Describes the various clinical presentations and toxic reactions caused by immunotherapy- Purchase includes access to the Elektronisches Buch for use on most mobile devices or computer.
